Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.
- NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_assertion wasGeneratedBy ECO_0000203 NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.
- NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_assertion wasDerivedFrom befree-20150227 NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.
- NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_assertion SIO_000772 18092840 NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.
- NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_assertion evidence source_evidence_literature NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.
- NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_assertion description "[This observation suggests the possibility that PPARalpha and PPARgamma activators, or compounds that positively regulate PPAR gene expression, may represent novel NSAIDs for the topical or systemic treatment of common inflammatory skin diseases such as atopic dermatitis, psoriasis, and allergic contact dermatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637614.RA_l-ii8N54vuy1JQ1bKx99V7vHWj3cJ5DfwY4S7ZuSrI130_provenance.